Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 42Lymphoma 37Lymphoma, Mantle-Cell 35Lymphoma, Non-Hodgkin 32Multiple Myeloma 30Lymphoma, Follicular 30Hodgkin Disease 23Recurrence 19Lymphoma, Large B-Cell, Diffuse 19Lymphoma, B-Cell, Marginal Zone 18Waldenstrom Macroglobulinemia 12Leukemia 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, B-Cell 9Neoplasms, Plasma Cell 7Lymphoma, T-Cell 6Leukemia, Myeloid, Acute 6Burkitt Lymphoma 6Myelodysplastic Syndromes 5Leukemia, B-Cell 5Hematologic Neoplasms 5Sezary Syndrome 4Neoplasms 4Mycosis Fungoides 4Immune System Diseases 4Small Cell Lung Carcinoma 3Neoplasm Metastasis 3Myeloproliferative Disorders 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Bendamustine Hydrochloride × Clear all
NCT01891227 2018-11-07

MBC-6

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 2 Completed
40 enrolled
Breast

Breast Neoplasms

NCT00834678 2018-04-17

Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase 1/2 Completed
11 enrolled 16 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00661739 2011-09-02

RiTa

GBG Forschungs GmbH

Phase 1 Completed
38 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡